Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
NeoGenomics

NeoGenomics (NASDAQ: NEO) insider transactions

In the twelve months to 10 November 2026, executives and directors of NeoGenomics reported 5 open-market sales of 73,658 shares ($967,816) and 0 open-market purchases, by 4 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in NeoGenomics shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
1 October 2026Stone WarrenPres & Chief Operating OfficerOption exercise+17,562—198,640Form 4
1 October 2026Stone WarrenPres & Chief Operating OfficerShares withheld for tax−6,911—191,729Form 4
1 September 2026Olivo Alicia CEVP, GC & Business DevelopmentShares withheld for tax−2,692—90,875Form 4
21 August 2026Stone WarrenPres & Chief Operating OfficerOption exercise+28,106—192,138Form 4
21 August 2026Stone WarrenPres & Chief Operating OfficerShares withheld for tax−11,060—181,078Form 4
4 August 2026Aunan Greg DChief Accounting OfficerOpen-market sale−20,000$16.075,153Form 4
15 June 2026Tetrault Lynn A.DirectorOpen-market sale, 10b5-1 plan−5,307$11.1086,115Form 4
9 June 2026Tetrault Lynn A.DirectorOpen-market sale, 10b5-1 plan−5,307$11.2991,422Form 4
1 June 2026Green Marjorie CDirectorOption exercise+22,964—22,964Form 4
1 June 2026Gunn NeilDirectorOption exercise+23,077—51,177Form 4
1 June 2026Kanovsky Stephen MDirectorOption exercise+23,077—75,421Form 4
1 June 2026Kelly Michael AaronDirectorOption exercise+23,077—67,086Form 4
1 June 2026Perez David BrianDirectorOption exercise+23,077—56,967Form 4
1 June 2026Tetrault Lynn A.DirectorOption exercise+23,077—96,729Form 4
1 June 2026Williams FeliciaDirectorOption exercise+23,077—30,237Form 4
1 June 2026Kenny John P.DirectorOption exercise+5,893—5,893Form 4
11 May 2026Stone WarrenPres & Chief Operating OfficerOption exercise+5,830—167,815Form 4
11 May 2026Stone WarrenPres & Chief Operating OfficerShares withheld for tax−3,783—164,032Form 4
11 May 2026Olivo Alicia CEVP, GC & Business DevelopmentOption exercise+3,944—96,126Form 4
11 May 2026Olivo Alicia CEVP, GC & Business DevelopmentShares withheld for tax−2,559—93,567Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the NeoGenomics page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.